Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations), as amended from time to time, Krishna Institute of Medical Sciences has informed that the Board of Directors of the Company at its meeting held today January 4, 2025 based on the recommendation of Nomination and Remuneration Committee has approved the appointment of Suresh Natwarlal Patel (DIN: 07202263) as an Additional Director of the Company in the category of an Independent Director (Non-Executive) with effect from January 4, 2025 for a term of upto 5 consecutive years subject to approval by the Shareholders of the Company. Further, in accordance with the Circulars dated June 20, 2018, issued by the BSE and National Stock Exchange of India and based on affirmation given by Suresh Natwarlal Patel, it has confirmed that he is not debarred from holding the office of Director by virtue of any order of Securities and Exchange Board of India (SEBI) or any other such authority. The board meeting commenced at 11:30 am (IST) and concluded at 12:30 pm (IST) today.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7089.85 |
Max Healthcare Inst | 1209.45 |
Narayana Hrudayalay | 1330.20 |
Aster DM Healthcare | 515.25 |
Global Health | 1068.75 |
View more.. |